Since the drug and its metabolites are excreted by the kidneys, reduced clearance in patients with renal dysfunction can lead to accumulation and increased toxicity. The liver enzyme CYP2C9 plays a vital role in this conversion, which influences the drug’s onset and duration of action.
Ketorolac IM Injection for Acute Pain Management in Emergency and Post-Operative Settings
Similarly, liver disease can impede the metabolic conversion of the prodrug, altering the efficacy and safety profile, which underscores the importance of patient-specific assessment before administration. The intramuscular dose is typically 30 mg to 60 mg, while the intravenous dose ranges from 15 mg to 30 mg, highlighting that dosing is weight-based and renal function-dependent.
The IM route is particularly useful in emergency departments or post-operative recovery when patients are unable to take oral medications or require faster pain relief. This route offers the fastest onset of action, often within minutes, making it suitable for procedural sedation or severe pain management in inpatient settings.
Ketorolac IM Injection for Acute Pain Management in Emergency and Post-Operative Settings
This method is favored for its reliable absorption and relatively rapid onset of action, typically providing analgesic effects within 30 to 60 minutes. Understanding Ketorolac Pharmacokinetics The pharmacokinetics of ketorolac are complex and vary significantly based on the route of administration.
More About Ketorolac route of administration
Looking at Ketorolac route of administration from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Ketorolac route of administration can make the topic easier to follow by connecting earlier points with a few simple takeaways.
